ALKBH5 exhibits elevated expression in HBV–HCC tissues, moderate expression in paracancerous tissues, and diminished expression in normal liver tissues, suggesting its potential as a biomarker for diagnosing the progression of HBV‐related HCC [621]. This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.